Trastuzumab (Herceptin), Paclitaxel, Carboplatin and Gemcitabine in Advanced Urothelial Cancer
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Maha Hussain, MD
The University of Michigan Comprehensive Cancer Center
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
11 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- California City of Hope National Medical Group
Duarte, California, United States
- Usc/norris Comprehensive Cancer Center
Los Angeles, California, United States
- U.C. Davis Medical Center
Sacramento, California, United States
- University of Colorado
Aurora, Colorado, United States
- the University of Michigan Comprehensive Cancer Center
Ann Arbor, Michigan, United States
- Wayne State University
Detroit, Michigan, United States
- Roswell Park Cancer Institute
Buffalo, New York, United States
- Columbia Presbyterian Medical Center
New York, New York, United States
- Weill Medical College of Cornell University
New York, New York, United States
- University of Pennsylvania Cancer Center
Philadelphia, Pennsylvania, United States
- University of Pittsburgh Cancer Institute
Pittsburgh, Pennsylvania, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 30 Sept 2000
- Primary completion
- 31 Aug 2004
- Completion
- 31 Oct 2007
- Last update posted
- 21 Jan 2015
- Registered enrollment
- 33
- Registry id
- NCT00151034
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.